sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released a Form 8.3 disclosure, revealing its stake in Mural Oncology plc. As of September 16, 2025, Vanguard held a total of 770,979 ordinary shares of Mural Oncology, representing a 4.46% interest. This disclosure falls under Rule 8.3 of the Irish Takeover Panel Act, 1997.
Specifics detailed in the disclosure show no additional parties involved apart from Mural Oncology. The group's dealings included the sale of 32 ordinary shares at $2.07 each. No cash-settled or stock-settled derivatives were reported in the form.
Furthermore, Vanguard confirmed the absence of any indemnity, option arrangement, or any agreement that could influence transactions in Mural Oncology's relevant securities. There were also no voting agreements or plans for future securities dealings associated with this position.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.